Form 4: J.H. Whitney Equity Partners VII, LLC Sells Aveanna Healthcare Holdings Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


J.H. Whitney Equity Partners VII, LLC reports the sale of Aveanna Healthcare Holdings shares through a pre-arranged Rule 10b5-1 trading plan.

Summary

  • J.H. Whitney Equity Partners VII, LLC, a 10% owner of Aveanna Healthcare Holdings, Inc. (AVAH), filed a Form 4 detailing changes in beneficial ownership.
  • The filing reports sales of common stock on May 12 and May 13, 2025, executed under a Rule 10b5-1 trading plan adopted on December 13, 2024.
  • On May 12, 2025, 30,429 shares were sold at a weighted average price of $5.72, with prices ranging from $5.62 to $5.84.
  • On May 13, 2025, 27,883 shares were sold at a weighted average price of $5.86, with prices ranging from $5.84 to $5.89.
  • These sales were conducted by J.H. Whitney VII, L.P., PSA Healthcare Investment Holding LLC, and PSA Iliad Holdings LLC.
  • Following these transactions, J.H. Whitney VII, L.P. beneficially owns 31,261,092 shares, PSA Healthcare Investment Holding LLC beneficially owns 15,618,377 shares, and PSA Iliad Holdings LLC beneficially owns 1,445,901 shares.
  • J.H. Whitney Equity Partners VII, LLC is the general partner of J.H. Whitney VII, L.P. and Whitney Strategic Partners VII, L.P., which is the managing member of PSA Healthcare Investment Holding LLC and PSA Iliad Holdings LLC.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock sales. It doesn't inherently convey positive or negative sentiment, but rather reports factual transactions. The use of a 10b5-1 plan suggests a planned and orderly disposal of shares.

Industry Context

Sales by large shareholders are common and can be part of portfolio management strategies or pre-arranged trading plans. The use of a 10b5-1 plan suggests the sales were planned in advance to avoid insider trading concerns.

Stakeholder Impact

  • The stock sales could potentially exert downward pressure on the share price in the short term.
  • Shareholders may interpret the sales as a signal from a major holder, although the 10b5-1 plan mitigates this concern.

Key Dates

DateDescription
12/13/2024Date of adoption of Rule 10b5-1 trading plan
05/12/2025Date of first reported stock sale
05/13/2025Date of second reported stock sale
05/14/2025Date of Form 4 filing

Keywords

Form 4, Aveanna Healthcare Holdings, AVAH, J.H. Whitney Equity Partners VII, Rule 10b5-1, Beneficial Ownership, Stock Sale

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.